Table 3.
Colon Study | DLBCL Study | Leukemia Study | |||||
Ordering | Tumor | Normal | DLBCL | FL | ALL | AML | |
π1 | Xi <Xj <Xk | 0.125 | 0.045 | 0.362 | 0 | 0.340 | 0 |
π2 | Xi <Xk <Xj | 0.4 | 0 | 0.569 | 0 | 0 | 0.04 |
π3 | Xj <Xi <Xk | 0.075 | 0.864 | 0.052 | 0 | 0.660 | 0 |
π4 | Xj <Xk <Xi | 0 | 0.091 | 0 | 0.684 | 0 | 0.08 |
π5 | Xk <Xi <Xj | 0.4 | 0 | 0.017 | 0.053 | 0 | 0.76 |
π6 | Xk <Xj <Xi | 0 | 0 | 0 | 0.263 | 0 | 0.12 |
Prostate1 Study | Lung Study | GCM Study | |||||
Ordering | Cancer | Normal | MPM | ADCA | Tumor | Normal | |
π1 | Xi <Xj <Xk | 0.04 | 0 | 0 | 0.12 | 0.8 | 0.222 |
π2 | Xi <Xk <Xj | 0.1 | 0 | 0 | 0.827 | 0.113 | 0.5 |
π3 | Xk <Xi <Xk | 0.02 | 0.115 | 0.258 | 0.007 | 0.079 | 0.022 |
π4 | Xj <Xk <Xi | 0.06 | 0.807 | 0.742 | 0 | 0 | 0.044 |
π5 | Xk <Xi <Xj | 0.5 | 0.019 | 0 | 0.02 | 0.008 | 0.179 |
π6 | Xk <Xj <Xi | 0.28 | 0.059 | 0 | 0.027 | 0 | 0.033 |
Each portion of the corresponds to one study with two phenotypes. For each study and each phenotype, the table shows the relative frequencies of the six possible orderings among the expression values of the top-scoring triple for the samples in the study. The gene triple (gi, gj, gk) for each study is given in Table 4